Cytodyn Inc (CYDY)

[eetrog]

Your remaining shares they can offer to sell are not enough to bring them into 2H19. AS 600MM will be increased, no doubts, they always did. They are good at that.

You are all hyped about TNBC, but that phase-2 investigational trial takes you into 2020/22 only to be followed by another costly phase-3 trial, if the FDA is not converting it into a pivotal trial. And lately FDA is not very supportive with CYDY.

None of the 50 cents investors from the offerings are holding, they all dump when they get their chance and a bid allows them to do so.
They don't like to hold this when the stock is diving below their purchase price, especially when equity gets diluted one more time with the AS increase.

Mono may succeed one day in 2021, but without partnership retail is paying the bill.
Personally, I don't know why there is no deal already being done or at least in negotiations, but planning is not good enough.
Maybe the boards is too greedy, maybe none has not only no interest in combotherapy (admitted by CEO in last radio interview) but also no interest in monotherapy and so forth.

Stock is traded on the OTC and as many know here, nobody is buying it in volume. Just traded between your own hands with added liquidity downwards from the regular sales.

Therefor, this is a lemon to me and hence my last name.
72 hours are over.